Examples of using Tredaptive in English and their translations into Romanian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
Like other nicotinic acid medicinal products, Tredaptive is contraindicated in patients with significant or unexplained hepatic dysfunction.
Taking aspirin before you take Tredaptive does not reduce your flushing more than taking Tredaptive alone.
Hypophosphatemia As with other nicotinic acid medicinal products, Tredaptive was associated with small decreases in phosphorus levels.
It is not known if Tredaptive will harm your unborn baby.• You are breast-feeding or plan to breast-feed.
How to take• Take Tredaptive once a day, in the evening or at bedtime.• Take Tredaptive with food.• Swallow each tablet whole.
Tredaptive is used in addition to diet
As with other nicotinic acid medicinal products, Tredaptive(2,000 mg/40 mg)
As with other nicotinic acid medicinal products, Tredaptive(2,000 mg/40 mg)
its metabolites are excreted through the kidneys, Tredaptive should be used with caution in patients with renal dysfunction.
Tredaptive is not recommended for use in children under 18 years of age because of a lack of information on its safety and effectiveness in this group.
Tredaptive contains nicotinic acid,
more of prolonged-release nicotinic acid can initiate Tredaptive at the 2000 mg/ 40 mg dose.
If you forget to take Tredaptive• If you miss a dose,
In Tredaptive tablets, laropiprant is in one of the layers, and the other layer contains nicotinic acid.
However, if you do not take Tredaptive for 7 or more days in a row, talk to your doctor before restarting Tredaptive.
If Tredaptive is missed for less than 7 consecutive days,
Tredaptive should be used in patients in combination with HMG-CoA reductase inhibitors(statins),
The effect on lipids was similar whether Tredaptive was given as monotherapy or was added to ongoing statin therapy with
Tredaptive should be used with caution in patients who consume substantial quantities of alcohol and/or have a past history of liver disease.
The European Commission granted a marketing authorisation valid throughout the European Union for Tredaptive to Merck Sharp& Dohme Ltd. on 3 July 2008.

